MedTrace Logo

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

NCT01317329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-03-06

No results posted yet for this study

Summary

The purpose of this study is to determine the factors that are associated with improved cardiovascular function with the use of CPAP therapy on subjects diagnosed with moderate to severe obstructive sleep apnea.

Conditions

  • Sleep Apnea, Obstructive
  • Hypoxia
  • Hypercapnia
  • Sleep Disorders
  • Obesity
  • Hypertension
  • Coronary Artery Vasospasm
  • Right Ventricular Overload
  • Left Ventricular Function Systolic Dysfunction
  • Ventricular Hypertrophy

Interventions

OTHER

Clinically prescribed CPAP therapy

CPAP as prescribed by attending physician

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Claudia E Korcarz, DVM · University of Wisconsin, Madison

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01317329 on ClinicalTrials.gov